Long-Term Mechanical Circulatory Support in 198 Patients: Largest Single-Center Experience Worldwide

Authors:
  • MDMichael Dandel
    Michael Dandel
  • TKThomas Krabatsch
    Thomas Krabatsch
  • EPEvgenij Potapov
    Evgenij Potapov
  • ASAlexander Stepanenko
    Alexander Stepanenko
  • EHEwald Hennig
    Ewald Hennig
  • HLHans Brendan Lehmkuhl
    Hans Brendan Lehmkuhl
  • MPMiralem Pasic
    Miralem Pasic
  • YWYuguo Weng
    Yuguo Weng
  • RHRoland Hetzer
    Roland Hetzer

Abstract
During recent years, mechanical circulatory support (MCS) devices have been increasingly used for long-term support. Nevertheless, problems of embolic and bleeding complication, infections, and technical failure still inhibit successful permanent support. We analyzed the courses of 198 patients who were supported for >1 year by 12 different MCS devices. Of the 198 patients, 87 had first-generation MCS devices (pulsatile), 43 second-generation devices (nonpulsatile with standard bearings), and 68 third-generation devices (nonpulsatile with magnetic bearings), implanted between July 1994 and March 2009. The mean time on support of the total group was ∼ 2 years (690 ± 321 [366-1,875] days). Of the first generation, 83 patients (95%) could be discharged; in the second and third group, all patients could be discharged. Rehospitalizations were observed in all patients. Reasons for readmission were coagulation disorders, wound infections, stroke, and technical failure. Seventy-seven patients received heart transplantation, 66 are still receiving support, 53 died, and two patients have been weaned from the device. All types of devices can be used for extended periods of time. Device- and nondevice-related rehospitalizations were observed in all three groups of patients. Close outpatient monitoring and support are crucial to ensure good long-term results.

This publication has 11 references indexed in Scilit: